Medical Journals

N-terminal Hamartin-binding and C-terminal Gap Domain of Tuberin Can Separate in Vivo.

Authors:
  • Momose Shuji
  • Kobayashi Toshiyuki
  • Tada Norihiro
  • Itoyama Shinji
  • Hino Okio

From: Department of Pathology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda-tsujimichi, Kawagoe, Saitama 350-8550, Japan.

Biochemical and biophysical research communications

  • Publish Date: May 2007
  • ISSN: 0006-291X
  • Volume: 356
  • Issue: 3
  • Pages: 693-8
  • Medium: Print
  • Language: English
  • Citation (JAMA): Momose Shuji, Kobayashi Toshiyuki, Tada Norihiro, et al. N-terminal Hamartin-binding and C-terminal Gap Domain of Tuberin Can Separate in Vivo.. Biochem. Biophys. Res. Commun. May 2007;356:693-8

Abstract

The Eker rat is an animal model of renal carcinogenesis and carries a transposon insertion in the Tsc2 (tuberous sclerosis-2) gene. We previously generated transgenic Eker rats and identified coding sequences in the Tsc2 gene that are responsible for suppression of renal carcinogenesis in Eker rats. Tsc2-RGH, a transgene that expresses the carboxy terminal region (amino acids 1425-1755) of the Tsc2 product (tuberin), partially suppressed renal carcinogenesis. However, Tsc2-DRG, which expresses a mutant tuberin lacking the carboxy-terminal region (Delta aa 1425-1755), did not suppress renal carcinogenesis. Here, we found that introduction of both Tsc2-RGH and Tsc2-DRG in Eker rats completely suppressed renal carcinogenesis and rescued homozygous (Tsc2(Ek/Ek)) mutants from embryonic lethality in a complementary manner. Co-introduction of Tsc2-RGH and Tsc2-DRG, but not introduction of either alone, efficiently suppressed phosphorylation of p70 S6K. Thus, the functional domains of N-terminal hamartin binding and C-terminal tumor suppression in tuberin can separate in vivo.

Mesh Headings (Keywords): Animals, Animals, Genetically Modified, Ethylnitrosourea, Extracellular Signal-Regulated MAP Kinases, GTPase-Activating Proteins, Kidney, Kidney Neoplasms, Protein Structure, Tertiary, Rats, Signal Transduction, Tumor Suppressor Proteins


Check for Full Text / PubMed Unique Identifier (PMID): 17379185


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.